Safety & Risk ManagementPsilocybin

Pahnke’s ‘Good Friday Experiment’: a long-term follow-up and methodological critique

This methodological critique and long-term, between-subjects, follow-up study (n=16) challenges how the mystical experiences occasioned by psilocybin were measured during Walter Pahnke's infamous 'Good Friday experiment' (1963) on the basis of its imprecise questionnaire assessment and unsuccessful placebo blinding. However, all psilocybin subjects participating in the long-term follow-up, but none of the controls, still considered their original experience to have had genuinely mystical elements and to have made a uniquely valuable contribution to their spiritual lives even 27 years after.

Authors

  • Rick Doblin

Published

Journal of Transpersonal Psychology
individual Study

Abstract

Introduction

To investigate the potential of psychedelic drugs to facilitate mystical experience, W. Pahnke (1963) administered psilocybin or placebo to 20 White male Protestant divinity students before Good Friday services. The present study critiques the preparation phase of the experiment, Pahnke's questionnaire for measuring mystical experience, and completeness of his reporting.

Methods

Between 1986 and 1989, the present author recorded personal interviews with 16 of the original Ss. All 16 were re-administered the 100-item questionnaire used for 6-mo follow-up in the original experiment. The original experiment found that psilocybin Ss who experienced a mystical experience would, after 6 mo, report a substantial amount of positive, and virtually no negative, persisting changes in attitude and behavior.

Results

The present study further supports these findings.

Available with Blossom Pro

Research Summary of 'Pahnke’s ‘Good Friday Experiment’: a long-term follow-up and methodological critique'

Introduction

Pahnke's 1962 "Good Friday" experiment administered psilocybin or a placebo to twenty Protestant divinity students during a Marsh Chapel Good Friday service to test whether psychedelics could facilitate mystical experiences. Earlier reports of the study argued that psilocybin recipients reported more elements of a classical mystical experience and greater persisting positive changes than controls, but raw data from the original project were lost and subsequent legal restrictions prevented replication for decades. Doblin conducted a long-term follow-up and methodological critique roughly 24–27 years after the original study. The follow-up aimed to locate the original participants, re-administer Pahnke's six-month questionnaire, conduct tape-recorded interviews, and reassess both the empirical findings and the original study's methods — in particular the adequacy of the blinding, the questionnaire, and reporting of adverse events.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (1)

Papers cited by this study that are also in Blossom

Adverse Reactions to Psychedelic Drugs - A Review of the Literature

Strassman, R. J. · Journal of Nervous and Mental Disease (1984)

273 cited

Cited By (29)

Papers in Blossom that reference this study

Insights on Psychedelics: A Systematic Review of Therapeutic Effects

Kugel, J., Laukkonen, R., Yaden, D. B. et al. · Neuroscience and Biobehavioral Reviews (2025)

Psychedelics and psychological strengths

Brasher, T., Rosen, D., Spinella, M. · International Journal of Wellbeing (2023)

Neural Mechanisms and Psychology of Psychedelic Ego Dissolution

Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)

Human behavioral pharmacology of psychedelics

Strickland, J. C., Johnson, M. W. · Advances in Pharmacology (2022)

5 cited
Great Expectations: Recommendations for improving the methodological rigor of psychedelic clinical trials

Aday, J. S., Heifets, B. D., Pratscher, S. D. et al. · Psychopharmacology (2021)

Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD

Davis, A. K., Streeter Barrett, F., Griffiths, R. R. et al. · Journal of Psychopharmacology (2021)

108 cited
Entheogenic Experience and Spirituality

Johnstad, P. G. · Method and Theory in the Study of Religion (2020)

Tripping on nothing: placebo psychedelics and contextual factors

Olson, J. A., Suissa-Rocheleau, L., Lifshitz, M. et al. · Psychopharmacology (2020)

Cessation and reduction in alcohol consumption and misuse after psychedelic use

Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)

211 cited
States and traits related to the quality and consequences of psychedelic experiences

Russ, S. L., Carhart-Harris, R. L., Maruyama, G. et al. · Psychology of Consciousness Theory Research and Practice (2019)

Show all 29 papers
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

Richards, W. A., Garcia-Romeu, A. · International Review of Psychiatry (2018)

143 cited
A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience

Neitzke-Spruill, L., Glasser, C. · Journal of Psychoactive Drugs (2018)

High dose psilocybin is associated with positive subjective effects in healthy volunteers

Nicholas, C. R., Henriquez, K. M., Gassman, M. C. et al. · Journal of Psychopharmacology (2018)

61 cited
Phenomenology, Structure, and Dynamic of Psychedelic States

Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

Of Roots and Fruits A Comparison of Psychedelic and Nonpsychedelic Mystical Experiences

Yaden, D. B., Le Nguyen, K. D., Kern, M. L. et al. · Journal of Humanistic Psychology (2016)

90 cited
Psychedelics

Nichols, D. E. · Pharmacological Reviews (2016)

New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca

McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)

Serotonergic Hallucinogen-Induced Visual Perceptual Alterations

Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

Psilocybin - Summary of knowledge and new perspectives

Tylš, F., Páleníček, T., Horacek, J. · European Neuropsychopharmacology (2013)

Psychedelics and mental health: a population study

Krebs, T. S., Johansen, P. ˚. Ø. · PLOS ONE (2013)

Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin

MacLean, K. A., Leoutsakos, J. S., Johnson, M. W. et al. · Journal for the Scientific Study of Religion (2012)

350 cited
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

Studerus, E., Kometer, M., Hasler, F. et al. · Journal of Psychopharmacology (2010)

423 cited
Unauthorized Research on Cluster Headache

Sewell, R. A. · Preprints (2008)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Pahnke’s ‘Good Friday Experiment’: a long-term... — Research Summary & Context | Blossom